Hypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic Study
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The ASPIRE in-clinic study established that automatic suspension of insulin with the threshold suspend (TS) feature reduces the duration of induced hypoglycemia. The study's crossover design allowed the effects of antecedent hypoglycemia to be studied. SUBJECTS AND METHODS: The study enrolled 50 subjects who exercised until plasma glucose (YSI glucose and lactate analyzer; YSI, Inc., Yellow Springs, OH) reached ≤85 mg/dL. Hypoglycemia was evaluated after the YSI value reached <70 mg/dL. In TS experiments, insulin was stopped for 2 h once a sensor glucose (SG) value of ≤70 mg/dL was detected; in control experiments, basal insulin delivery continued. Subjects were randomly assigned to Group A (TS in Period 1; control in Period 2) or Group B (control in Period 1; TS in Period 2). Experiments were separated by 3-10 days. RESULTS: Hypoglycemia was 63.7 min shorter in Period 1 TS experiments (no preceding control experiment) than in Period 2 TS experiments (one or more preceding control experiment(s)) (P<0.01). The number of experiments prior to a successful TS experiment was lower for Period 1 than for Period 2 (0.36 ± 0.64 vs. 1.57 ± 0.84; P<0.001), as was the cumulative duration of antecedent hypoglycemia (16.6 min vs. 204.6 min; P<0.001). The between-groups difference in hypoglycemia duration was not attributable to differences in SG rates of change, the duration of exercise, or area under the curve of <70 mg/dL × min in the 2 days before the successful experiment (all P>0.3). CONCLUSIONS: The TS feature's ability to mitigate hypoglycemia was decreased by an episode or episodes of prolonged antecedent hypoglycemia, suggesting hypoglycemia begets hypoglycemia. The effect of antecedent hypoglycemia should be taken into consideration in the design of future experiments assessing strategies to reduce hypoglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652 · cited 1×
“11 The ASPIRE in-clinic study’s crossover design allowed comparison of subjects’ recovery from hypoglycemia under various conditions and showed that recent hypoglycemia is detrimental to recovery from subsequent hypoglycemia.”
Self-citationKönig, M., Bulik, S., & Holzhütter, H.-G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002577 · Cited by 202 · cited 1×
“When basal insulin delivery is suspended during hypo-glycemia, the liver and sympathoadrenal system play critical roles in the timing and magnitude of recovery, and a detailed mathematical model of hepatic glucose metabolism 13 suggests a multifaceted etiology for the order effect.”
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
Choudhary, P., Shin, J., Wang, Y., Evans, M. L., Hammond, P. J., Kerr, D., Shaw, J. A. M., Pickup, J. C., & Amiel, S. A. (2011) · Diabetes Care · doi:10.2337/dc10-2411 · Cited by 175
Self-citationGarg, S., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., Shin, J., Welsh, J. B., & Kaufman, F. R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0292 · Cited by 138 · cited 1×
“Attempted induction experiments 69 (35, 34) 50 (25, 25) 65 (33, 32) 50 (25, 25) Failed induction experiments 21 (10, 11) 14 (8, 6) 15 (8, 7) 12 (6, 6) YSI ‡ 70 mg/dL 9 (5, 4) 8 (5, 3) 5 (3, 2) 5 (3, 2) YSI < 50 mg/dL 9 (3, 6) 5 (2, 3) 8 (3, 5) 7 (3, 4) Others 3 (2, 1) 3 (2, 1) 2 (2, 0) 2 (2, 0) Sensor dislodged 1 (1,…”
Self-citationDeath during intensive glycemic therapy of diabetes: mechanisms and implications
Cryer, P. E. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.08.008 · Cited by 137 · cited 1×
“Attempted induction experiments 69 (35, 34) 50 (25, 25) 65 (33, 32) 50 (25, 25) Failed induction experiments 21 (10, 11) 14 (8, 6) 15 (8, 7) 12 (6, 6) YSI ‡ 70 mg/dL 9 (5, 4) 8 (5, 3) 5 (3, 2) 5 (3, 2) YSI < 50 mg/dL 9 (3, 6) 5 (2, 3) 8 (3, 5) 7 (3, 4) Others 3 (2, 1) 3 (2, 1) 2 (2, 0) 2 (2, 0) Sensor dislodged 1 (1,…”
Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition
Arbelaez, A. M., Powers, W. J., Videen, T. O., Price, J. L., & Cryer, P. E. (2008) · Diabetes · doi:10.2337/db07-1329 · Cited by 92
Cited by
Physical activity/exercise and diabetes: A position statement of the American Diabetes Association
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., Horton, E. S., Castorino, K., & Tate, D. F. (2016) · Diabetes Care · doi:10.2337/dc16-1728 · Cited by 2,991
“Inclusion of a bedtime snack, glucose checks overnight, and/or use of CGM with alarms and automatic pump suspensionmay also bewarranted (141,142).”
BackgroundExercise management in type 1 diabetes: a consensus statement
Riddell, M. C., Gallen, I. W., Smart, C. E., Taplin, C. E., Adolfsson, P., Lumb, A. N., Kowalski, A., Rabasa-Lhoret, R., McCrimmon, R. J., Hume, C., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30014-1 · Cited by 903
Metrics for glycaemic control - from HbA1c to continuous glucose monitoring
Kovatchev, B. P. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.3 · Cited by 272
Benhamou, P.-Y., Franc, S., Reznik, Y., Thivolet, C., Schaepelynck, P., Renard, E., Guerci, B., Chaillous, L., Lukas-Croisier, C., Jeandidier, N., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30003-2 · Cited by 217
Adolfsson, P., Riddell, M. C., Taplin, C. E., Davis, E. A., Fournier, P. A., Annan, F., Scaramuzza, A. E., Hasnani, D., & Hofer, S. E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12755 · Cited by 191
“cise associated with hypoglycemia occurred, LGS technology may not be as effective in ameliorating hypoglycemia risk.(104) Taplin et al attempted to prevent nocturnal hypoglycemia after a”
BackgroundA clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm
Messer, L. H., Berget, C., & Forlenza, G. P. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0105 · Cited by 100
“The MiniMed 630G (MiniMed, Northridge, CA) is an example of a low glucose suspend system that suspends insulin delivery when sensor glucose levels are in the hypoglycemic range.(6,7)”
Background
Metadata
- Authors
- Garg, S. K., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., Shin, J., Welsh, J. B., & Kaufman, F. R.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2014-03
- Volume
- 16
- Issue
- 3
- Pages
- 125-130
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W1532110865
- Cited by
- 28
- References
- 6
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.